Hydroxyurea therapy in E-β-thalassemia:: Effect on hemoglobin and on RBC characteristics.

被引:0
|
作者
Singer, ST
Kuypers, F
Mignacca, R
Kennedy, N
Olivieri, N
Weatherall, D
Vichinsky, E
机构
[1] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA
[2] Valley Childrens Hosp, Fresno, CA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1878
引用
收藏
页码:424A / 424A
页数:1
相关论文
共 48 条
  • [21] Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in beta-thalassemia hemoglobin E disease
    Fucharoen, S
    Siritanaratkul, N
    Winichagoon, P
    Chowthaworn, J
    Siriboon, W
    Muangsup, W
    Chaicharoen, S
    Poolsup, N
    Chindavijak, B
    Pootrakul, P
    Piankijagum, A
    Schechter, AN
    Rodgers, GP
    BLOOD, 1996, 87 (03) : 887 - 892
  • [22] α0-thalassemia in affected fetuses with hemoglobin E-β0-thalassemia disease in a high-risk population in Thailand
    Yamsri, Supawadee
    Prommetta, Simaporn
    Srivorakun, Hataichanok
    Taweenan, Wachiraporn
    Sanchaisuriya, Kanokwan
    Chaibunruang, Attawut
    Fucharoen, Goonnapa
    Fucharoen, Supan
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (02): : 1315 - 1323
  • [23] The Effect and Side Effect of Hydroxyurea Therapy on Patients With β-Thalassemia: A Systematic Review to December 2012
    Kosaryan, Mehrnoush
    Zafari, Mandana
    Alipur, Abbass
    Hedayatizadeh-Omran, Akbar
    HEMOGLOBIN, 2014, 38 (04) : 262 - 271
  • [24] Response to sodium phenylbutuyrate and hydroxyurea in thalassemia: Possible effect of marrow expansion on augmentation of fetal hemoglobin (HbF).
    Taylor, CM
    DiMonte, L
    Waye, J
    Weatherall, DJ
    Premawardena, A
    Efremov, G
    Dimovski, A
    Weerasinghe, D
    Zisovski, N
    Olivieri, NF
    BLOOD, 2000, 96 (11) : 561A - +
  • [25] Blood transfusion therapy for β-thalassemia major and hemoglobin E β-thalassemia: Adequacy, trends, and determinants in Sri Lanka
    Mettananda, Sachith
    Pathiraja, Hashan
    Peiris, Ravindu
    Wickramarathne, Nethmi
    Bandara, Dayananda
    de Silva, Udaya
    Mettananda, Chamila
    Premawardhena, Anuja
    PEDIATRIC BLOOD & CANCER, 2019, 66 (05)
  • [26] THERAPEUTIC BENEFIT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN AND HYDROXYUREA IN HEMOGLOBIN-E - BETA-DEGREES-THALASSEMIA SYNDROME
    VADAKAN, V
    SLEIGHT, GW
    VADAKAN, V
    BLOOD, 1994, 84 (10) : A559 - A559
  • [27] Rheological properties of sickle erythrocytes in patients with sickle-cell anemia: The effect of hydroxyurea, fetal hemoglobin, and α-thalassemia
    Ballas, Samir K.
    Connes, Philippe
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (06) : 798 - 803
  • [28] Effect of alpha (0)-thalassemia, β-thalassemia and hemoglobin E genes on anemia:: comparison between males and females
    Yamsri, S.
    Sanchaisuriya, K.
    Fucharoen, G.
    Fucharoen, S.
    Sae-ung, N.
    Jetsrisuparp, A.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2008, 30 : 136 - 136
  • [29] Role of Genomic Biomarkers in Increasing Fetal Hemoglobin Levels Upon Hydroxyurea Therapy and in β-Thalassemia Intermedia: A Validation Cohort Study
    Kolliopoulou, Alexandra
    Siamoglou, Stavroula
    John, Anne
    Sgourou, Argyro
    Kourakli, Alexandra
    Symeonidis, Argiris
    Vlachaki, Efthymia
    Chalkia, Panagiota
    Theodoridou, Stamatia
    Ali, Bassam R.
    Katsila, Theodora
    Patrinos, George P.
    Papachatzopoulou, Adamantia
    HEMOGLOBIN, 2019, 43 (01) : 27 - 33
  • [30] Ten year-old male with hemoglobin Lufkin/beta-zero Thalassemia compound heterozygote who exhibited beta-thalassemia major characteristics.
    Blutreich, AM
    Shu, PH
    Bragdon, JS
    Kurtin, PJ
    Hoyer, JD
    Karayalcin, G
    BLOOD, 2005, 106 (11) : 33B - 33B